More on the Cohort-Component Model of Population
Projection in the Context of HIV/AIDS: A Leslie
Matrix Representation and New Estimation Methods
Jason Thomas & Samuel J. Clark1
University of Washington, Seattle

Working Paper no. 88
Center for Statistics and the Social Sciences
University of Washington
2008-11-20

1 Department

of Sociology, University of Washington (Jason Thomas and Samuel J. Clark PhD),
Institute of Behavioral Science (IBS), University of Colorado at Boulder, CO, USA and MRC/Wits
Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health,
University of the Witwatersrand, Johannesburg, South Africa (Samuel J. Clark). Correspondence
to Samuel J. Clark: samclark@u.washington.edu. The project described here was supported by a
seed grant from the Center for Statistics and the Social Sciences (CSSS), University of Washington
and by grant numbers 1 K01 HD057246-01 and 1 R01 HD054511 01 A1 from the National Institute
of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH). The
content of the work presented here is solely the responsibility of the authors and does not necessarily
represent the official views of the the NIH. The authors are grateful to Patrick Heuveline for his
correspondence and for making his work available. We also thank Leontine Alkema, Le Bao, Jennifer
Chunn, Jeff Eaton, Marie-Louise Newell and Adrian Raftery for invaluable discussion during the
preparation of this work. The first author would also like to thank the Africa Centre for Health
and Population Studies, University of KwaZulu-Natal for their hospitality and useful comments on
an early version of this work.

Abstract
This article presents an extension of the cohort component model of population projection
(CCMPP) first formulated by Heuveline (2003) that is capable of modeling a population
affected by HIV. Heuveline proposes a maximum likelihood approach to estimate the age
profile of HIV incidence that produced the HIV epidemics in East Africa during the 1990s.
We extend this work by developing the Leslie matrix representation of the CCMPP which
greatly facilitates implementation of the model for parameter estimation and projecting.
The Leslie matrix also contains information about the stable tendencies of the corresponding population, such as the stable age distribution and time to stability. We validate our
reformulation of the model by comparing parameter estimates obtained through maximum
likelihood and bootstrap methods to those presented by Heuveline using Heuvelineâ€™s original
data set. A further application of the model to a small population with high HIV prevalence
in rural South Africa is presented as an additional demonstration. This work lays the foundation for development of more robust and flexible Bayesian estimation methods that will
greatly enhance the utility of this and similar models.
KEY WORDS: Model, Cohort-Component, Leslie Matrix, Estimation, HIV, Incidence,
Prevalence, Africa.

Contents
1 INTRODUCTION

4

2 CCMPP

5

2.1

The HIV Incidence Trend . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7

2.2

Additional HIV-related Force of Mortality . . . . . . . . . . . . . . . . . . .

9

2.3

Matrix Notation for HIV-enabled CCMPP . . . . . . . . . . . . . . . . . . .

13

3 PARAMETER ESTIMATION

16

3.1

Types of Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

17

3.2

Likelihoods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

18

3.2.1

HIV Test Results in a General-Population Sample . . . . . . . . . . .

19

3.2.2

HIV Test Results in an ANC-Patient Sample . . . . . . . . . . . . . .

19

3.2.3

HIV Test Results in all or a Sample of Births from HIV+ Mothers . .

20

3.2.4

HIV Test Results During a Follow-up of an HIVâ€“ Sample . . . . . . .

20

3.2.5

Survival During a Follow-up of HIV+ Individuals . . . . . . . . . . .

21

Estimation Techniques . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

22

3.3

4 RESULTS

22

5 DISCUSSION

31

REFERENCES

32

1

List of Tables
1

Five-Year Incidence Rates Calculated from the Gamma Density and an Exponential Curve. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8

Expected Number of Person-Years Lived Over a Five-Year Interval by Survival
Schedule and Duration Group. . . . . . . . . . . . . . . . . . . . . . . . . . .

10

3

Survival Probabilities Applied to HIV+ (sa,d>1 ). . . . . . . . . . . . . . . . .

12

4

Life Table for HIV+ Women Infected at Age 15.

. . . . . . . . . . . . . . .

13

5

Estimates of CCMPP Parameters and 95% Confidence Intervals. . . . . . . .

24

6

Comparison of Model Fit to Data on Age-Specific HIV Prevalence from Kapiri
Mposhi, Zambia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

25

CCMPP Parameter Estimates and 95% Confidence Intervals using Data from
KwaZulu-Natal, South Africa. . . . . . . . . . . . . . . . . . . . . . . . . .

27

2

7

2

List of Figures
1

Age-specific HIV incidence rates, ia,t , for different values of the populationspecific scale parameter, H, over time. . . . . . . . . . . . . . . . . . . . . .

6

2

Projected Prevalence Over Time for Women Aged 15-49. . . . . . . . . . . .

28

3

Projected Prevalence Over Time for Men Aged 15-54. . . . . . . . . . . . . .

29

4

Projected Population Pyramids at 25 Year Intervals for KwaZulu-Natal South
Africa. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

30

3

1

INTRODUCTION

The cohort component model of population projection (CCMPP) is perhaps the iconic
method in demography, see for example Bowley (1924); Cannan (1895); Whelpton (1936);
Leslie (1945); Pritchett (1891); Pearl and Reed (1920); Dorn (1950). This classic method
increments forward in time a population defined by age according to a specified life table and
set of age-specific fertility rates, taking into account net migration at each age. In its basic
form it is straightforward and easy to implement which has allowed it to become one of the
essential tools used by governments and planning organizations to help them understand the
likely future size and composition of a population, and how that may change under different
assumptions or as a result of interventions of various types.
Fundamentally the CCMPP relates the age structure of a population to fertility, mortality
and migration, with the current age structure being the result of fertility, mortality and
migration at each age in the past. Most commonly a future age structure of the population
is â€˜predictedâ€™ given a time series of age-specific fertility, mortality, and net migration. The
model can also be used to estimate trends in a subset of the four components given the
others, and it is a use of this type that occupies us here.
The HIV epidemic affecting Africa and other parts of the developing world poses significant
challenges to demographers concerned with either measuring the current state of an affected
population or predicting its future. Because HIV affects both fertility and mortality in
important ways (for example: Ford and Hosegood, 2005; Garenne et al., 2007; Gregson
et al., 2007; Hunter et al., 2003; Kahn et al., 2007; Lewis et al., 2004; Nyirenda et al., 2007;
Terceira et al., 2003; Timaes and Jasseh, 2004; Wachter et al., 2002; Zaba and Gregson, 1998;
Zaba et al., 2007; Carpenter et al., 1997; Gray et al., 1998; Nunn et al., 1997; Sewankambo
et al., 1994; Todd et al., 1997), it is not possible to understand the dynamics of a population
affected by HIV without specifically taking into account these effects. Further complicating
this situation, data describing underlying fertility and mortality unaffected by HIV are scarce
and often of poor quality, especially for most populations with high HIV prevalence.
These challenges are addressed in an interesting and useful way in a model developed by
Heuveline (2003). Heuveline created a multi-state version of the standard CCMPP model
(Day, 1996; United Nations, 2004) that further classifies the population by time since infection with HIV and uses a set of age-specific incidence parameters to â€˜infectâ€™ HIV negative
people and transition them to the first (shortest duration) HIV positive group. This version
of the model also includes additional parameters to govern the links between HIV status
and fertility. Heuveline used data describing HIV status and survival (mortality) from East
African countries to estimate these model parameters using maximum likelihood techniques.
This article provides a detailed description of Heuvelineâ€™s multi-state, HIV-enabled CCMPP
and two different procedures used to estimate its parameters, the maximum likelihood
method employed by Heuveline and an approach based on bootstrap methods. The first
section provides a detailed introduction to the CCMPP and presents the Leslie matrix representation that we have created for it. Following is a description of the data and methods
used to estimate the model parameters. Next, to validate both our new implementation and
Heuvelineâ€™s original work, we present our new parameter estimates obtained from an analysis
4

of the same data used by Heuveline in his original work. Finally, we apply the model to a
rural population in South Africa with high HIV prevalence and present estimates of the key
parameters describing that population.

2

CCMPP

Heuveline (2003) extends the standard CCMPP to accommodate a population categorized
by duration of infection with HIV using five â€˜HIV durationâ€™ groups. There are four HIV+
duration groups (0-4 years, 5-9 years, 10-14 years, and 15+ years) as well as an HIVâ€“ group.
In this section we present Heuvelineâ€™s multi-state CCMPP for a population with 17 age
groups (0-4, 5-9, . . . , 80+) in each of the five HIV duration groups. The model is introduced
with a series of equations representing the transition from one group/time period to the
next. While the model can be applied to both men and women, the description presented
here only includes the details for women.
Begin by dividing the population into age groups where a = 1, 2, . . . , 17 correspond to age
groups 0-4, 5-9, . . ., 80+. Denote membership in the HIV duration groups by d, with
d = 1, 2, . . . , 5 corresponding to HIVâ€“, HIV+ for 0-4 years, . . . , HIV+ for more than 15
years. Time is indexed by t noting that the duration between t and t + 1 is equal to the
width of a standard age interval, e.g. 5 years. Let na,d,t be the number of women in age
group a and duration group d at time t. For 1 < a < 17, we have:
na+1,1,t+1 = na,1,t sa,1,t (1 âˆ’ ia,t )
na+1,2,t+1 = na,1,t sa,1,t ia,t sa,2
na+1,d,t+1 = na,dâˆ’1,t sa,1,t sa,d for d > 2

(1)
(2)
(3)

where sa,d is the survivorship ratio for age group a and duration group d. Note that for
2 < d < 5 this survivorship ratio determines the transition from one age group to the next,
as well as from one duration group to the next. Each HIV+ group is exposed to the same
underlying base survivorship ratio as the HIVâ€“ group in addition to this extra survivorship
ratio that accounts for the increased mortality associated with different durations of infection.
The parameter ia,t is the fraction of women in age group a who become infected with HIV over
the projection interval. To allow for the heterogeneity of HIV epidemics across populations,
this parameter is decomposed as:
ia,t = 1 âˆ’ exp {âˆ’Î“tâˆ’t0 H ja }

(4)

where Î“tâˆ’t0 is a parametric curve used to model the time trend in the HIV epidemic from
the start time t0 . The actual values for Î“tâˆ’t0 are presented in Table 1 (see the next section
for more details). The parameter H is a population-specific scale parameter that captures
the overall magnitude of the epidemic. The parameter ja is an age- and sex-specific scaling
factor for incidence that represents the multiplicative difference in HIV incidence between
age group a and a reference age group which is held constant at a value of 1.0 in order to
make the model identifiable. Following Heuveline we set the reference age group to 25-29,
i.e. j5 = 1.0.
5

Figure 1: Age-specific HIV incidence rates, ia,t , for different values of the population-specific
scale parameter, H, over time.
5 yrs

10 yrs
0.4
HIV Incidence

HIV Incidence

0.4
0.3
0.2
0.1

0.3
â—

0.2

â—

â—

0.1

â—

â—

â—

â—

â—

â—

â—
â—

â—

0.0

â—
â—

â—

15âˆ’9

â—

â—
â—

â—

25âˆ’9

â—
â—

â—

â—
â—

35âˆ’9

â—
â—

â—
â—

45âˆ’9

â—
â—

0.0

55âˆ’9

15âˆ’9

â—

25âˆ’9

35âˆ’9

â—

â—

45âˆ’9

Age Group

Age Group

15 yrs

20 yrs

â—

55âˆ’9

0.4
â—

0.3

â—

0.2

â—

â—

â—

â—
â—

â—

0.1

â—

HIV Incidence

0.4
HIV Incidence

â—

â—

0.3
â—
â—

0.2

â—

0.1

â—

0.0

â—

â—

â—

â—

â—

â—

â—
â—

â—

0.0

â—

â—

â—

15âˆ’9

25âˆ’9

â—

35âˆ’9

â—

â—

â—

45âˆ’9

â—

â—

55âˆ’9

15âˆ’9

Age Group

â—

â—

25âˆ’9

35âˆ’9

â—

45âˆ’9

â—

â—

55âˆ’9

Age Group

For a given age profile of incidence (a specific set of values for ja ), Figure 1 demonstrates
how the different values for H simple scale the incidence profile. Each panel in this figure
corresponds to a different time in the epidemic with incidence whose overall scale is determined by the values of Î“. Within each panel, each line corresponds to a value of the
population-specific scale parameter H ranging from 0.1 to 1.0.
The projection equations are slightly different for the youngest and oldest age groups. The
oldest (open-ended) age group is incremented by two sources, those 75-79 and 80+ in the
previous time period. Thus for a = 17 we have:
n17,1,t+1 = n16,1,t s16,1,t (1 âˆ’ i16,t )
+ n17,1,t s17,1,t (1 âˆ’ i17,t )
n17,2,t+1 = n16,1,t s16,1,t i16,t s16,2
+ n17,1,t s17,1,t i17,t s17,2
n17,d,t+1 = n16,dâˆ’1,t s16,1,t s16,d
+ n17,dâˆ’1,t s17,1,t s17,d for 2 < d < 5
n17,5,t+1 = n16,4,t s16,1,t s16,5 + n17,4,t s17,1,t s17,5
+ n16,5,t s16,1,t s16,5 + n17,5,t s17,1,t s17,5

6

(5)
(6)
(7)
(8)

As with the single-state CCMPP, the number of children in the first age group at the end of
the projection interval is determined by surviving forward the births that occur during the
projection interval. The number of births that occur is calculated by applying age-specific
fertility rates to the average number of women in each age group during the projection
interval, taking into account the fact that HIV+ women who have been infected for different
durations will to varying degrees be less likely to have children. To capture the relationship
between fertility and HIV status, Heuveline defined three additional parameters. First,
consider the number of HIVâ€“ births:
1
Ã—
n1,1,t+1 = s0,1,t
1 + SRB
ï£«
ï£¶
Î²
Î²
âˆ’
5 X
X
X
n
+
p
n
a,1,t
aâˆ’1,1,t aâˆ’1,1,t
âˆ’ na,d,t + paâˆ’1,dâˆ’1,t naâˆ’1,dâˆ’1,t ï£¸
ï£­
+
(9)
fa,1,t
fa,d,t
2
2
a=Î±
d=2 a=Î±
In Equation 9 above, the fa,1,t â€™s are simply the age-specific fertility rates for HIVâ€“ women,
and the lower and upper bounds of the childbearing age range are Î± and Î². Fertility among
HIV+ women introduces the following parameters
âˆ’
fa,d,t
= fa,1,t ea gd (1 âˆ’ v)

(10)

âˆ’
for 1 < d. The superscript in fa,d,t
designates HIVâ€“ births to women who are HIV+ (i.e. d >
1). The parameter vd is the probability that an HIV+ woman in duration group d will give
birth to an HIV+ child, the vertical transmission rate. The parameter ea captures the higher
level of sexual activity and resulting fertility among HIV+ women age 15-19 who have been
infected for 0-4 years (d = 2), accounting for the selection of more sexually active teenagers
into the HIV+ category. In other words we expect ea=4 > 1 while ea6=4 are constrained to be
1.0. The parameter gd represents the fertility impairment experienced by women in duration
group d , a number that becomes smaller as the time since infection increases reflecting
increasing fertility impairment with time since infection. The corresponding equations for
HIV+ births are:

n1,2,t+1 = s0,1,t

Î²
5 X
X
na,d,t + paâˆ’1,dâˆ’1,t naâˆ’1,dâˆ’1,t
1
+
fa,d,t
1 + SRB d = 2 a = Î±
2

+
fa,d,t
= fa,1,t ea gd v

(11)
(12)

Finally, we define the factors used to approximate the average number of women at the
beginning and end of the period, pâˆ’
a,1,t and pa,d,t :
pâˆ’
a,1,t = sa,1,t (1 âˆ’ ia,t )
pa,1,t = sa,1,t ia,t sa,2
pa,d,t = sa,1,t sa,d for d > 1.

2.1

(13)
(14)
(15)

The HIV Incidence Trend

Age-specific incidence in CCMPP is modeled as follows:
ia,k,t = 1 âˆ’ exp {âˆ’Î“t, t0 H ja,k }
7

(16)

Table 1: Five-Year Incidence Rates Calculated from the Gamma Density and an Exponential
Curve.
Time Period Î“t, t0 Et, t0
0 - 5 years
0.028 0.063
6 - 10 years
0.216 0.191
11 - 15 years
0.316 0.323
16 - 20 years
0.235 0.457
20+ yearsa
0.163 0.540
a

For the gamma model it is assumed that the HIV incidence rate will level off at the rate equal to the
integral of the gamma density from 20 and 21 multiplied by five. For the exponential model it is assumed
that the HIV incidence rate will level off at a rate equal to 5 âˆ— (h(t = 21) âˆ’ h(t = 20)). See the text for the
definition of h(t).

where ia,k,t is the fraction of individuals age a who will become infected over the projection
interval. Î“t, t0 represents the shape of the incidence trend from the start of the epidemic
in year t0 to the projection period t. This incidence trend is shifted up or down by H, an
overall scale parameter for the epidemic. Finally, ja,k is the incidence rate ratio comparing
those of age a and sex k to women age 25-29. The details of the incidence trend Î“t, t0 are
described in this section, along with several other possible specifications.
The incidence trend Î“t, t0 used by Heuveline (2003) is borrowed from EpiModel, a computer
program developed by the World Health Organization to make short-term projections of
adult AIDS cases (Chin and Lawnga, 1991) and the precursor of UNAIDSâ€™ estimation and
projection package (EPP) software currently used to estimate the prevalence of HIV (Ghys
et al., 2004). Î“t, t0 is based on the gamma family of distributions:
g(t) =

tÎ±âˆ’1 eâˆ’x/Î²
,
(Î± âˆ’ 1)!Î² Î±

for t â‰¥ 0, Î± > 0 Î² > 0

(17)

The Î± parameter is typically referred to as the shape parameter since it affects how peaked
or flat the density is, as Î± increases the density appears more flat or uniform. The scale
parameter Î² is associated with how diffuse or spread out the density is, as Î² increases the
density spreads out.
Before discussing the calculations made by Heuveline (2003) it is helpful to discuss a particular property of the gamma distribution. The mode, or value for which the the function
reaches its maximum, is equal to (Î± âˆ’ 1)Î². This quantity has a nice interpretation in that
it is the number of years after the start of the epidemic t0 when the epidemic peaks. For
example, if the shape parameters is 5 and the scale parameter is 3, then the epidemic peaks
12 years after it began1 .
This is precisely the density used by Heuveline (2003) to calculate the five-year incidence
rates, i.e. Î± = 5, Î² = 4. The actual rates are calculated by integrating the gamma density
1

Chin and Lawnga (1991) report that setting Î± = 5 results in â€œthe best empirical â€˜fitâ€™ to the reported
AIDS-case curves in countries with reliable case-reporting systems.â€ They set Î² = 1.

8

over the appropriate five-year span, i.e:
t5âˆ’1 eâˆ’x/4
dt for t âˆˆ {5, 10, 15, 20}
tâˆ’5 (5 âˆ’ 1)!45
Z 21 5âˆ’1 âˆ’x/4
t e
= 5Ã—
dt for t > 20
20 (5 âˆ’ 1)!45

Î“tâˆ’t0 =
Î“tâˆ’t0

Z t

(18)
(19)

The five-year incidence rate for twenty years after the start date is different because the
decline in the gamma density for values greater than 20 is too rapid to represent an actual
decline in incidence. The values used to estimate the CCMPP parameters are presented in
Table 1. We are aware that this is relatively crude, and it would be preferable to model this
trend using time series techniques with attention given to the uncertainty around the trend,
especially at time points far into the future. That is among the improvements that currently
occupy us.
We will now discuss two other possible specifications for the trend in HIV incidence. The first
is an exponential curve that models a continual increase in HIV over time. While this may
not be realistic in the long run it does provide an upper bound for the trend. A reasonable
lower bound is a constant rate of new infections (i.e. no increase) over time. Since the second
specification is simply a constant2 we will focus our attention on the exponential model.
The exponential curve used to model the trend in HIV incidence takes the following functional
form:
eÎ²t
âˆ’ t for t = 1, 2, 3, . . . ; and Î² > 0
(20)
h(t) =
Î²
The five-year HIV incidence rates are calculated by differencing h(t) (at lag one) and summing over the five year period of interest:
Et, t0 =

5
X

h(t) âˆ’ h(t âˆ’ 1)

(21)

j=1

Heuveline (2003) chooses a value of Î² = 0.005 to obtain the five-year HIV incidence rates
based on the exponential model, shown in Table 1. Finally, similar to the gamma model
described above, the incidence rate after twenty years takes a different form. For the exponential curve, E20+,t0 = 5 Ã— (h(t = 21) âˆ’ h(t = 20)).

2.2

Additional HIV-related Force of Mortality

In the HIV-enabled CCMPP individuals infected with HIV (d > 1) experience an additional
force of mortality that is not experienced by those in the HIVâ€“ state (d = 1). This mortality
differential can be seen in the following projection equations
na+1,d = 2,t+1 = na,d = 1,t sa,d = 1,t ia,t sa,d = 2
na+1,d > 2,t+1 = na,dâˆ’1,t sa,d = 1,t sa,d > 2
2

Heuveline (2003) uses 0.2 as the five-year incidence rate.

9

(22)
(23)

Table 2: Expected Number of Person-Years Lived Over a Five-Year Interval by Survival
Schedule and Duration Group.

Duration Group
0 to 0-4
(d=2)
0-4 to 5-9
(d=3)
5-9 to 10-4 (d=4)
10-4 to 15-9 (d=5)

3
2.7750
0.4250
0.0000
0.0000

Survival Schedule
8
11
4.7100
4.8000
2.4300
3.3750
0.8600
2.0000
0.3150
1.0000

12
4.8310
3.6000
2.4125
1.5375

where sa,d > 1 < 1; survival in the HIV+ states is reduced compared to the HIVâ€“ state. Recall
that the vital rates (mortality and fertility) in CCMPP are treated as fixed parameters and
need to be set by the user.
Heuveline turns to the epidemiological literature for guidance on choosing values for the survival rates of individuals infected with HIV. One of the more important findings (concerning
the HIV-enabed CCMPP) is that that the progression from HIV to death is faster for older
individuals. Morgan et al. (2002) report this finding in a study of a cohort from rural Uganda
for whom the time of HIV infection is reasonably well known. Their data include 10, 18,
and 19 deaths among 65, 68, and 35 participants in age groups 15-24, 25-39, and 40+ years.
The cumulative probability of survival for each group is 79% (95%CI: 63-88%), 72% (95%CI:
56-83%), and 20% (95%CI: 6-40%), respectively. Morgan et al. (2002) also report a faster
progression from seroconversion to AIDS for the oldest age group (40+ years).3
Given the evidence from the epidemiological literature, Heuveline (2003) specifies the survival
rates for HIV+ individuals as a function of age at infection. This dependence comes through
in the choice of a particular survival schedule, defined by the median number of years lived
after infection. The schedules include median survival times of 3, 8, 10, and 12 years.
Children who are infected perinatally follow the 3 year schedule, while the oldest age groups
follow the 8-year schedule. Before describing the age dependence in greater detail, it is
helpful to take a slight digression and define some more notation.
Heuveline (2003) defines these survival schedules with reference to the projection interval
(i.e. five years). Let yd,m be the expected number of person-years lived by an individual in
duration group d following survival schedule m, where m = 3, 8, 11, 12. For example, the
average number of years lived by a person infected 5-9 years ago who is following the survival
schedule with a median survival time of 11 years is yd = 3,m = 11 = 3.375. The values for yd,m
(see Table 2) are estimated from distributions of median survival time of those infected with
HIV (Heuveline, 2003; Chin, 1994).
Now we are in a position to define sa,d > 1 . Let us begin with those who have been infected
for 0-4 years (d = 2). Children born and infected (perinattaly) during the projection interval
are exposed to:
yd=2,m=3
(24)
sa=1,d=2 =
5
3

In this same study, the median time from seroconversion to AIDS is 9.4 years, IQR: 5.5 â€“ 10.1 years.
The median time from seroconversion to death is 9.8 years, IQR: 6.1 â€“ > 10.3 years (Morgan et al., 2002).

10

The HIV-related survival ratios for the next two age groups are defined to be 1.0 because
persons between the of ages 5 and 9 are not able to be infected given our current assumptions
about incidence, recall that the age-specific incidence rates are zero for the first three age
groups. (This might not be the best assumption since infants are still able to become infected
via breastfeeding.) For those who are ages 15-19, 25-34, or above age 45, the additional force
of mortality caused by HIV takes a form similar to the equation just above:
sa=4,d=2
s8 â‰¥ a â‰¥ 6,d=2
sa â‰¥ 10,d=2

=
=
=

yd=2,m=12
5
yd=2,m=11
5
yd=2,m=8
5

=
=
=

0.9662
0.9600
0.9420

(25)
(26)
(27)

Note how survival declines as age increases before leveling off at age 45 and older. For the age
groups not already mentioned, the survival parameters are calculated by taking the average
over two adjacent survival schedules:
sa=5,d=2

=

sa=9,d=2

=

yd=2,m=11 +yd=2,m=12
2
yd=2,m=8 +yd=2,m=11
2

=

0.9631

(28)

=

0.9651

(29)

We now turn our attention to the third duration group, individuals who have been infected
for 5-9 years. For this group, we start with those aged 5-9:
sa=2,d=3 =

yd=3,m=3
.
yd=2,m=3

(30)

The corresponding parameters for the older age groups take a similar form. The expected
number of person-years lived for the third duration group is divided by the expected number
of person-years lived by the second duration group (for a given survival schedule). The
dependence on age for d = 3 takes the same form as for the previous duration group, only
that the age groups are incremented by one. The actual equations are:
sa=5,d=3 =
sa=6,d=3 =
s9â‰¥aâ‰¥7,d=3 =
sa=10,d=3 =
saâ‰¥11,d=3 =

yd=3,m=3
yd=2,m=3
yd=3,m=12 + yd=3,m=11
yd=2,m=12 + yd=2,m=11
yd=3,m=11
yd=2,m=11
yd=3,m=11 + yd=3,m=8
yd=2,m=11 + yd=2,m=8
yd=3,m=8
yd=2,m=8

(31)
(32)
(33)
(34)
(35)

The pattern continues for the fourth and fifth duration groups. All of the parameters for
the additional force of mortality due to HIV are listed in Table 3.
Life tables can also be constructed using the survival rates presented in Table 3, where cohorts
defined by age at infection are exposed to the survival rates aligned along the diagonal cells
11

Table 3: Survival Probabilities Applied to HIV+ (sa,d>1 ).
HIV Duration Group
Age Group
0-4 yrs 5-9 yrs 10-4 yrs 15+ yrs
(d = 2) (d = 3)
(d = 4)
(d = 5)
0-4
0.5550
â€“
â€“
â€“
5-9
â€“
0.1532
â€“
â€“
10-4
â€“
â€“
0.0000
â€“
15-9
0.9662
â€“
â€“
0.0000
20-4
0.9631
0.7452
â€“
â€“
25-9
0.9600
0.7242
0.6701
â€“
30-4
0.9600
0.7031
0.6326
0.6373
35-9
0.9600
0.7031
0.5926
0.5751
40-4
0.9510
0.7031
0.5926
0.5000
45-9
0.9420
0.6104
0.5926
0.5000
50-4
0.9420
0.5159
0.4927
0.5000
55-9
0.9420
0.5159
0.3539
0.4598
60-4
0.9420
0.5159
0.3539
0.3663
65-9
0.9420
0.5159
0.3539
0.3663
70-5
0.9420
0.5159
0.3539
0.3663
75-9
0.9420
0.5159
0.3539
0.3663
80+
0.9420
0.5159
0.3539
0.3663

12

Table 4: Life Table for HIV+ Women Infected at Age 15.
Age Group
15
20
25
30
35
40
45
50
55
60
65
70
75
80

n px

n qx

0.9566
0.7347
0.6587
0.6255
0.5634
0.4883
0.4863
0.4823
0.4370
0.3388
0.3220
0.2940
0.2500
0.1586

0.0434
0.2653
0.3413
0.3745
0.4366
0.5117
0.5137
0.5177
0.5630
0.6612
0.6780
0.7060
0.7500
0.8414

lx
100,000
95,655
70,274
46,291
28,953
16,311
7,965
3,873
1,868
816
276
89
26
6

n dx

n Lx

4,345 489,138
25,381 414,822
23,983 291,412
17,338 188,110
12,642 113,160
8,346 60,690
4,092 29,595
2,005 14,352
1,052
6,710
540
2,730
187
912
63
288
20
80
6
21

0

e
Tx
1,612,020 16.1202
1,122,882 11.7389
708,060 10.0757
416,648 9.0006
228,538 7.8934
115,378 7.0736
546,88 6.8660
25,093 6.4789
10,741 5.7498
4,031 4.9395
1,301 4.7125
389 4.3669
101 3.8713
21 3.4425

of the table. For example children infected by their mothers will never reach age 15 years
because the survival probability is zero for those infected at birth and between the ages of 10
and 14. The mortality experienced by the cohort of women infected at age 15 is summarized
in the life table presented in Table 4.
The size of the cohort exposed to the mortality risks in Table 4 is reduced to half after
fifteen years. After thirty years there is just under ten percent of the cohort still living.
While the survival experience of this cohort may seem plausible, it is preferable to have the
their survival rates informed by data. The current specification for the survival experience
results in a stable population with unappealing characteristics. This point is discussed later
on in the paper.

2.3

Matrix Notation for HIV-enabled CCMPP

These equations for the multi-state, HIV-enabled CCMPP can be conveniently expressed in
matrix notation. For a population with 17 age groups and five HIV duration groups, the

13

population at time t is represented by an 85 Ã— 1 column vector:

nt =

ï£®

n1,1,t

ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£°

ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
n17,1,t ï£º
ï£º
.. ï£º
. ï£º
ï£º
ï£º
n1,4,t ï£º
ï£º
ï£º
n2,4,t ï£º
ï£º
ï£º
.. ï£º
. ï£º
ï£»

ï£¹

n2,1,t
..
.

(36)

n17,4,t

The corresponding Leslie matrix is:
ï£®

At =

ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£°

B1,1 B1,2 B1,3 B1,4 B1,5
B2,1 B2,2 B2,3 B2,4 B2,5
0 B3,2 0
0
0
0
0 B4,3 0
0
0
0
0 B5,4 B5,5

ï£¹
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£»

(37)

where Bi,j is a 17 Ã— 17 sub-matrix that models how group j at time t contributes to group
i at time t + 1. Note that B3,1 is a zero matrix since women who are HIVâ€“ at time t cannot
give birth to children who have been HIV positive for ten years by t + 1 (i.e. five years into
the future). Similar reasoning applies for the other zero submatrices.
The calculations involving B1,j produce the projection for the number of HIVâ€“ births (i.e.
n1,1,t+1 ) contributed by duration group j. Similarly, B2,j projects the number of HIV positive
births contributed by duration group j > 2. B1,1 and B2,1 are a little different in that they
project each age group to the next oldest age group and from one HIV duration group to
the next. Let us first consider B1,1 :
ï£®

bâˆ’
bâˆ’
ï£¯ 1,1,t 2,1,t

B1,1 =

ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£°

ï£¹

bâˆ’
17,1,t ï£º

Â·Â·Â·

pâˆ’
1,1,t

0

Â·Â·Â·

0

0

pâˆ’
2,1,t

...

..
.

...

0

0
..
.
0

0
..
.
0

...
Â·Â·Â·

...

0

0

0

pâˆ’
16,1,t

pâˆ’
17,1,t

ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º.
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£»

(38)

Recall that the number in the first age group at time t + 1 is equal to the number of births
summed across the fecund age groups. Let bâˆ’
a,d,t be the factor needed to calculate the number
14

of HIVâ€“ births to mothers in age group a at time t and in duration group d:
bâˆ’
a,1,t

= s0,1,t

naâˆ’1,1,t
1 + pâˆ’
aâˆ’1,1,t na,1,t
1
âˆ’
f
.
1 + SRB a,1,t
2

(39)

In our application of the multi-state, HIV-enabled CCMPP fertility only occurs among
âˆ’
women aged 15-49, i.e. Î± = 4, Î² = 10. Consequently bâˆ’
a < 4,1,t = ba > 10,1,t = 0. In
1+pâˆ’
aâˆ’1,1,t

naâˆ’1,1,t
n

a,1,t
is used to approximate the number of women at risk
Equation 39 the factor
2
4
of giving birth. If the count in the denominator na,1,t is ever zero the entire ratio is simply
replaced by zero. This issue arises when dealing with fertility of the HIV+ groups. The
same procedure is used the analogous HIV+ equations if they involve dividing by zero. Recall that the pâˆ’
aâˆ’1,d,t are the factors used to approximate the average number of women at
the beginning and end of the age group.

B1,d for d > 1 projects forward HIVâ€“ births contributed by duration group d and can be
written as:
ï£¹
ï£® âˆ’
âˆ’
âˆ’
b1,d,t bâˆ’
2,d,t b3,d,t Â· Â· Â· b17,d,t
ï£º
ï£¯
ï£¯ 0
Â·Â·Â·
0 ï£º
ï£º
ï£¯
ï£º
ï£¯
...
(40)
ï£º
B1,d = ï£¯ ...
ï£¯
ï£¯
ï£°

0

ï£º
ï£º
ï£»

0

where

n

)
1 + paâˆ’1,dâˆ’1,t ( aâˆ’1,dâˆ’1,t
1
na,d,t
âˆ’
fa,d,t
(41)
= s0,1,t
1 + SRB
2
for d > 1. The B2,d â€™s determine the number of people infected with HIV for less than five
years at time t + 1, contributed by those in duration group d at time t. For the first two
duration groups we have:
bâˆ’
a,d,t

ï£®

b+
b+
ï£¯ 1,1,t 2,1,t
ï£¯
ï£¯ p
0
ï£¯ 1,1,t
B2,1 =

ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£°

0
0
..
.
0

p2,1,t
0
..
.
0

ï£¹

b+
17,1,t ï£º

Â·Â·Â·
Â·Â·Â·

0

...

..
.

..

.

0

..

.

..

Â·Â·Â·

0

.

0

0

p16,1,t p17,1,t

ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£»

(42)

The model does now allow HIVâ€“ women to become infected and give birth to HIV+ children
in the same projection interval, zeros in the first rows. This assumption is justified by the
low level of infectivity during the first five years after infection.
4

In the matrix multiplication (i.e. the projection) this factor gets multiplied by the number of women in
the appropriate age group, na,1,t . The pâˆ’
aâˆ’1,1,t are defined in Equation ??.

15

B2,d for d > 1 projects forward the number of HIV+ births contributed by duration group
d. It can be written as:

B2,d =

ï£® +
b
ï£¯ 1,d,t
ï£¯ 0
ï£¯
ï£¯ ..
ï£¯ .
ï£¯
ï£¯
ï£°

+
+
b+
2,d,t b3,d,t Â· Â· Â· b17,d,t
Â·Â·Â·
0
...

0

where
b+
a,d,t

= s0,1,t s0,1,t

0

ï£¹
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£»

1 + paâˆ’1,dâˆ’1,t (
1
+
fa,d,t
1 + SRB
2

(43)

naâˆ’1,dâˆ’1,t
)
na,d,t

(44)

The remaining non-zero sub-matrices â€“ B3,2 , B4,3 , B5,4 and B5,5 â€“ project people forward
in both age and time, and consequently the only non-zero elements occur along the subdiagonal:
ï£¹
ï£®
0

Bi,j =

ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£¯
ï£°

0

p1,d = j,t

0

0

p2,d = j,t

0
..
.
0

0
..
.
0

Â·Â·Â·

0
..
.

Â·Â·Â·
..
.
...

0

...

...

Â·Â·Â·

0

0

0

p16,d = j,t p17,d = j,t

ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£º
ï£»

(45)

The Leslie matrix representation of the model greatly facilitates the implementation and use
of the multi-state, HIV-enabled CCMPP using the R programming language (R Development
Core Team, 2006). Repeated matrix multiplication produces the projected population at fiveyear intervals making it possible to explore the long term behavior of the population and the
epidemic. See the results section for an application to a population living in the KwaZuluNatal province of South Africa. Finally, if the Leslie matrix is irreducible and primitive then
we can explore the stable age distribution of the population (Keyfitz and Caswell, 2005).

3

PARAMETER ESTIMATION

The CCMPP projections are used to estimate thirty-two of the model parameters. As
mentioned earlier the vital rates, the initial population counts, and the HIV survival schedules
are all fixed. The parameters we are interested in estimating are:
â€¢ v: vertical transmission parameter that is constrained to be between 0 and 1; although
the model is described as having a vertical transmission rate for each duration group,
there are not enough data to estimate separate parameters â€“ (1)

16

â€¢ ea : fertility selection parameter that is constrained to be equal to 1 for all groups
except women aged 15-19 in the first HIV duration group, for whom we expect the
value to be greater than 1 â€“ (1)
â€¢ gd : fertility impairment parameter for women in duration group d, for d = 2, 3, 4; the
fertility impairment parameter for d = 5 is constrained such that gd=5 = gd=4 , and the
values for all duration groups are constrained to be between 0 and 1 â€“ (3)
â€¢ ja,k : relative incidence rate ratio parameter that is constrained to be equal to 1 for
women age 25-29 and non-negative for all other groups; values are estimated for women
(k = 1) age 15-19, 20-24, 30-34, 35-39, . . ., 55-59 and for men in the age groups between
15-59, i.e. 8 and 9 age-specific parameters for women and men, respectively â€“ (17)
â€¢ Hh : scale parameters for the trend in HIV incidence for population h â€“ (11)
For a given set of parameter values we obtain a set of not necessarily unique age- and sexspecific counts. These model outputs are used to calculate predicted values for the observed
data. For example the ratio of the projected number of HIV+ women age 20-25 over the total
number of women projected in that age group is used to predict the observed HIV prevalence
for women in that age group. Several types of observed data, such as HIV prevalence, are
used to estimate the values of the parameters that are most likely.
In this section we discuss this topic in greater detail. The first focus is on the types of data
used in the analysis. We then shift to the likelihoods specific to each type of data. Finally we
turn to the techniques used to estimate the parameters, namely maximum likelihood (ML)
estimation and a bootstrapping approach.

3.1

Types of Data

Heuveline (2003) uses data published in the literature to estimate the model parameters.
These data consist of observations from eleven different East African populations collected
from antenatal clinics (ANCs), demographic surveillance sites, hospitals and general surveys.
Both rural and urban areas are included, and the years of data collection range from 1989
to 1998. The data are classified into the following five categories (see Table 1, Heuveline,
2003):
1. HIV test results in a general-population sample (10 data sets)
2. HIV test results in an ANC-patient sample (3 data sets)
3. HIV test results in all or a sample of births from HIV+ mothers (3 data sets)
4. HIV test results during a follow-up of an HIV- sample (3 data sets)
5. Survival during a follow-up of HIV+ individuals (3 data sets)

17

The CCMPP outputs can be used to calculate predicted values for each type of data. These
calculations and the likelihoods used to compare the predicted values to the data are addressed in the next section.
It should also be mentioned that the CCMPP also requires vital rates for the uninfected
population and an initial age distribution. These model inputs are taken from the United
Nations global population estimates (United Nations, 1999) and model life tables (United
Nations, 1982).

3.2

Likelihoods

Each category of data provides the pieces needed for a proportion which leads to the use
of the binomial distribution in the likelihood specification. The binomial likelihood can be
written as:
!
Y N
L=
Ï€ x (1 âˆ’ Ï€)N âˆ’x
(46)
x
where N is the total number of events, x is the number of â€œsuccessesâ€, and Ï€ is the probability of success. The first two quantities N and x are taken from the data and we use
CCMPP to calculate Ï€, given values for the parameters.
Before discussing the finer details of how the CCMPP outputs are used in the likelihood,
it is important to cover two points. First, we need to temporally match up the CCMPP
projections with the observed data. The start year for the model is the year when widespread
transmission of HIV began, t0 . The population is then projected forward to the year when
the data were collected. For example if widespread transmission in a country began in 1980
and the observed data are from 2000, then we can take the projected counts 20 years from
the start time and compare these to the observed data. Given that the projections are in five
year increments it is sometimes necessary to take the average across two projection periods
to match the year of data collection. Estimates of when widespread HIV transmission began
are taken from a report by the United Nations (1998, Table 1).
Second, the data come from populations at eleven different locations.5 At a given location
there can also be several different types of data. For example data from the population living
in Mwanza, Tanzania include both HIV prevalence from a general population and survival
information for those who are HIV+. As a result there is a separate likelihood for the 23
combinations of location and data type retrieved from the literature. These are indicated
using h for the population (and location) and c for the type or category of data. Finally, the
data consist of sex- and age-specific information so the likelihoods may also be indexed by
these characteristics as well.
5

Bujumbura, Burundi; Mangochi, Malawi; Mara, Tanzania; Mwanza, Tanzania; Fort Portal, Uganda;
Gulu, Uganda; Masaka, Uganda; Rakai, Uganda; Lusaka, Zambia; Mposhi, Zambia and Mutasa, Zimbabwe.

18

3.2.1

HIV Test Results in a General-Population Sample

Various studies have collected data on sex- and age-specific HIV prevalence in a sample from
the general population (Kilian et al., 1999; Nunn et al., 1997; Wawer et al., 1991; Serwadda
et al., 1992; Shao et al., 1994; Grosskurth et al., 1995; Saidel et al., 1996; Fylkesnes et al.,
1998; Gregson and Garnett, 2000). The age groups range from 15-19 to 55-59. This type
of data, labeled â€˜1â€™ (c = 1), usually include the number of people tested and the percent
who tested positive for HIV by sex and age. The likelihood, however, requires a count of
individuals who are HIV+, so we calculate this quantity from the data and round it to the
nearest integer. Let Na,k,t,h,c = 1 denote the total number of individuals in age group a of sex
k at time t at location h and let xa,k,t,h,c = 1 be the number in this group who tested positive.
The projected counts from CCMPP na,d,t,h are used to predict sex- and age-specific prevalence
for a given location as follows:
P5

na,d,t,h
,
d=1 na,d,t,h

Ï€a,k,t,h,c=1 = Pd=2
5

(47)

where the sum is taken across HIV duration groups. Having chosen the projection period
that matches up with the year the data were observed, we can use Ï€a,k,t,h,c = 1 in the binomial
likelihood. A final note is that the observed data may be reported by age groups that do
not match those of our projections. In this case weighted sums of the projected counts can
be used to estimate HIV prevalence. For example if observed prevalence is reported for
individuals age 22-30, then predicted prevalence can be calculated as:
P5

(na=4,d,t,h Ã— 0.6 + na=5,d,t,h )
d=1 (na=4,d,t,h Ã— 0.6 + na=5,d,t,h )

Ï€age=(22âˆ’30),k,t,h,c=1 = P5d=2

(48)

This issue arises with the other data types as well.
3.2.2

HIV Test Results in an ANC-Patient Sample

Four of the data sets used in this analysis provide age-specific information on HIV prevalence
for female attendees of ANCs, typically from age 15 to 49 (Kilian et al., 1999; Fabiani et al.,
2001; Slutsker et al., 1994; Sokal et al., 1993). This type of data, indexed by c = 2, takes
a form similar to the observed prevalence from a general population except that they only
refer to women. Both the total number of women tested Na,k = 1,t,h,c = 2 and the age-specific
prevalence are reported. The data are included in the binomial likelihood as counts, so we
calculate the number of women who tested positive xa,k = t,h rounded to the nearest integer.
The predicted prevalence for the ANC attendees is calculated differently than for the general
population. Recall that there are two primary assumptions of CCMPP concerning the fertility of HIV+ women. The first is that HIV+ women age 15-19 have higher fertility which is
captured by the fertility selection parameter ea = 4 . Second, fertility is expected to decline as
time since infection increases; modelled by the fertility impairment parameters gd > 1 . Since
the HIV+ women observed in the data are pregnant, these parameters are included in the
19

calculation of predicted prevalence. The formula is:
P5

Ï€a,k = 1,t,h,c = 2 =

na,d,k=1,t,h Ã— ea Ã— gd
,
P
na,d,k = 1,t,h + 5d=2 na,d,k = 1,t,h Ã— ea Ã— gd
d=2

(49)

where the sum is taken over the duration groups. Having chosen the projection period that
matches up with the year the data were observed, we can use Ï€a,k = 1,t,h,c = 2 in the binomial
likelihood.
3.2.3

HIV Test Results in all or a Sample of Births from HIV+ Mothers

Heuveline (2003) found three data sets consisting of information on the fertility of HIV+
women. However one of these sources Hira et al. (1989) differs from the others in that it
provides information on whether or not an HIV+ mother infected her child. Data from the
other two sources, Carpenter et al. (1997) and Gray et al. (1998), consist of the number of
children born to both HIV+ and HIVâ€“ women, by age group. The likelihoods for the latter
two sources are nearly identical to those in the data category c = 2, HIV test results in an
ANC sample. The only difference is that the observed counts (i.e. the data) refer to the total
number of children born to female ANC attendees in a specific age group, and the number of
children born to HIV+ attendees. The probability that a child is born to an infected mother
is calculated exactly the same as Ï€a,k = 1,t,h,c = 2 . Given this similarity the data reported by
Carpenter et al. (1997) and Gray et al. (1998) are classified here as c = 2.
Data that take the form of Hira et al. (1989) will be indicated by c = 3. The corresponding
counts used in the likelihood refer to the total number of children born to infected mothers in age group o, No,t,h,c = 3 , and the number of these children who are infected by their
mothers xo,d = 2,t,h,c = 3 . The predicted rate of vertical transmission using the model outputs
is calculated as:
P5

Ï€o,t,h,c = 3 =

d=2 na,k=1,d,t,h Ã— fa,d = 1,t,h Ã— ea Ã— gd Ã—
P5
d=2 na,k=1,d,t,h Ã— fa,d=1,t,h Ã— ea Ã— gd

vd

,

(50)

where the sum is taken over the duration groups.
Unfortunately, this leaves only one data source to inform the estimate of the vertical transmission parameter. This issue is especially problematic when the parameter is constrained
to be equal across duration groups (i.e. vd = v, for all d). Note that all the like terms
in the numerator and denominator cancel out, so the projections have no influence on the
likelihood. Thus including more data of this type would be beneficial for future analysis
using this model.
3.2.4

HIV Test Results During a Follow-up of an HIVâ€“ Sample

Data on sex- and age-specific HIV incidence are also used to estimate CCMPP parameters.
These data indexed by c = 4 are typically reported in terms of the number of people who
20

become infected and the total number of person-years lived while uninfected (KengeyaKayondo et al., 1996; Wawer et al., 1994; Saidel et al., 1996). For the binomial likelihood
however, we need the counts of the initial population observed Na,t,d = 1,t,h,c = 4 and the number
of who become infected Xa,t,d = 2,t,h,c = 4 . Thus the initial population size needs to be calculated
from the observed data, and this calculation can be done as follows:
Initial Population =

# Converted

# Converted
1 âˆ’ exp âˆ’T Ã— Person-Years


(51)

where T is the total number of years observed.6
The model outputs are then used to calculate the probability of becoming infected for men
or women in a certain age group at a given location and time. That is:
Ï€a,k,d = 1,t,h,c = 4 =

na,k,d=1,t,h Ã— sa,k,d=1,t,h âˆ’ na+1,k,d=1,t+1,h
na,k,d=1,t,h Ã— sa,k,d=1,t,h

(52)

where Ï€a,k,d = 1,t,h,c = 4 is the proportion of HIVâ€“ women/men who become infected after five
years. As discussed earlier, the period of observation for the data may not be equal to
the projection interval of five years. If the observation period is only four years, then the
quantity of interest is calculated as:
(

# Converted
4
Ã— log 1 âˆ’
1 âˆ’ exp
5
Initial Population
3.2.5

!)

(53)

Survival During a Follow-up of HIV+ Individuals

The final category of data describes the survival (mortality) of HIV+ individuals presented
by Nunn et al. (1997); Sewankambo et al. (1994); Todd et al. (1997). This category indexed
by c = 5 is similar to the previous one in that the data reported include the number of deaths
observed among a cohort of HIV+ individuals of a particular age and sex Xa,k,t,h,c = 5 and the
number of person-years observed for each group. As before, the likelihoods require the initial
population size for each group Na,k,t,h,c = 5 (see Equation 51). These two inputs Xa,k,t,h,c = 5
and Na,k,t,h,c = 5 are the counts needed for the binomial likelihood with the corresponding
proportion referring to the probability of death over a given period of time.
The procedure for calculating the probability of death from the model outputs is best described in two steps. First, we calculate the probabilities by age, sex, and duration group.
This can be written as:
qa,k,d,t,h,c= 5

na+1,k,d+1,t+1,h
=1âˆ’
na,k,d,t,h

6

!T

5

for

d â‰¥ 2

(54)

In deriving this equation it is helpful to note that the number of person-years lived by a population of
T âˆ’N0 )Ã—T
initial size N0 and of size NT T years later is equal to (N
log(NT /N0 ) .

21

where T is the number of years over which the data were observed. Since the observed data
do not contain information on duration group, we must calculate the weighted average where
the weights are the counts in each duration group. This second step is performed as follows:
P5

Ï€a,k,t,h,c = 5 =

d=2 qa,k,d,t,h,c = 5

Ã— na,k,d,t,h

na,k,d,t,h

(55)

This is the probability used in the binomial likelihood.

3.3

Estimation Techniques

Maximum likelihood (ML) and bootstrapping techniques are used to estimate the most likely
parameter values and the uncertainty around those point estimates. We begin by discussing
the ML approach.
Given the data from an individual site, the likelihood of a specific set of CCMPP parameter values can be calculated using the binomial expressions described above. Twenty-two
likelihoods are calculated, one for each of the twenty-two locations from which data come.
We follow Heuveline (2003) and combine these likelihoods by taking the product across all
twenty-two locations and data types, assuming independence. The set of parameter values
that maximizes the combined likelihood is the ML point estimate.
The ML estimation as well as the implementation of CCMPP is performed using the R
programming language (R Development Core Team, 2006). This languages provides an
optimization routine optim that is used to find the parameter values that maximize the
combined likelihood described above. In addition optim calculates the Hessian matrix of the
likelihood function at the maximum. Standard errors are obtained by inverting the Hessian
matrix and taking the square root of the diagonal elements.
A bootstrapping procedure is also used for estimation. We begin by sampling with replacement within four of the five data categories described earlier. Recall that there is only one
data set providing information on the mother to child transmission of HIV, so this data set is
included every time. Thus we are unable to produce an estimate of the vertical transmission
parameter via this bootstrap technique. The ML estimates are then obtained using these
â€œnewâ€ data, the estimates are stored, and the process is repeated over 300 times. The resulting distribution of ML estimates is used to assess possible values for the CCMPP parameters.
Since the data sets are sampled with replacement some of the sites may not be included in
the estimation making it impossible to estimate the corresponding site-specific parameters.
Consequently the scale parameters H that indicate the size of the HIV epidemic for a given
site are not estimated using the bootstrap approach.

4

RESULTS

The parameter estimates and 95% confidence intervals for the model parameters obtained
by ML and bootstrap estimation are presented in Table 5 along with the original estimates
22

published by Heuveline (2003). Medians are used for the point estimates under the bootstrap
approach. Confidence intervals for the parameters governing the level of the HIV epidemic
for a given site were not reported by Heuveline. Lack of data and the characteristics of the
bootstrap procedure, discussed above, prevent us from estimating these scale parameters
and the vertical transmission parameters.
The point estimates for the parameters concerning both HIV and fertility are fairly similar
across the three estimation methods â€“ our ML and bootstrap methods and Heuvelineâ€™s ML
method. Judging by the ML estimates, just under forty percent of children born to HIV+
mothers are likely to be infected. There is quite a bit of uncertainty around the point
estimates, with the 95% confidence intervals stretching from 30% up to nearly 50%. This is
rather high compared to the findings of other studies in Africa which usually fall in the range
of 20-40% Working Group on Mother-To-Child Transmission (1995); Rollins et al. (2007).
Women age 15-19 who are infected have fertility that is considerably higher than women in
the same age group who are HIVâ€“.7 The point estimates for the fertility selection parameter
vary, but each estimate is well within the confidence intervals of the other two. Our intervals,
however, are much wider than those reported by Heuveline. This is also the case for the
fertility impairment parameters, particularly for the bootstrap estimates. The interval for
our ML estimate of the impairment parameter for women who have been infected for more
than ten years includes negative values that are clearly outside the natural range for this
parameter, and similarly the upper bound on the fertility impairment parameter for women
infected for less than five years is greater than one, also a â€˜nonphysicalâ€™ result as our colleagues
in the hard sciences would term it. Fertility is expected to decline as time since infection
increases, and both Heuvelineâ€™s and our ML estimates are consistent with this expectation,
but all of the ML point estimates show a slight increase over the bootstrap results. However,
the uncertainty around these estimates does not allow a definitive conclusion.
The point estimates of the relative incidence parameters for women are also similar across
the three sets of estimates. Incidence among women peaks at ages 20-24 and declines at older
ages. Again, we see more uncertainty around our estimates relative to Heuvelineâ€™s, with the
ML confidence interval including negative (and thus nonphysical) values. Another difference
is that our estimates for incidence of women ages 15-19 fall outside the 95% confidence
interval reported by Heuveline. Finally, uncertainty around the estimates increases with
age for each set of results which makes sense because there are fewer data describing HIV
incidence and prevalence at older ages.
Compared to women, incidence among men is estimated to peak at older ages. Heuvelineâ€™s
results show a peak in the late twenties while our results put the peak during the early
thirties. However, given the uncertainty in these estimates we are unable to definitively
pinpoint the peak. Aside from the later peak among men, the results are similar to those for
women. Some of our confidence intervals using ML techniques include nonphysical values,
and there is generally more uncertainty around our results at older ages.
7

The multiplicative factor by which fertility is higher among infected women is equal to the fertility
selection factor times the fertility impairment parameter of women infected less than five years. These
factors are 1.42, 1.58, and 1.58 for Heuvelineâ€™s analysis, our ML estimates and the bootstrap estimates,
respectively. This modification to fertility only applies while women are in the states of being within the
ages of 15 to 19, and being HIV+ for 0 to 4 years.

23

Table 5: Estimates of CCMPP Parameters and 95% Confidence Intervals.
Parameters
Vertical Transmission
Fertility Selection
Fertility Impairment
duration 0-4
duration 5-9
Duration 10+
Female Relative Incidence Ratio
15-9
20-4
25-9
30-4
35-9
40-4
45-9
50-4
55-9
Male Relative Incidence Ratio
15-9
20-4
25-9
30-4
35-9
40-4
45-9
50-4
55-9
Level Of HIV Epidemic
Bujumbura, Burundi
Mangochi, Malawi
Mara, Tanzania
Mwanza, Tanzania
Fort Portal, Uganda
Gulu, Uganda
Masaka, Uganda
Rakai, Uganda
Chelston, Zambia
Kapira Mposhi, Zambia
Mutasa, Zimbabwe

Heuveline
0.385
(0.297, 0.478)
1.672
(1.492, 1.865)

ML
0.395
(0.303, 0.487)
1.836
(1.331, 2.341)

Bootstrap
âˆ’âˆ’
âˆ’âˆ’
1.754
(1.28, 2.367)

0.848
(0.798, 0.909)
0.357
(0.276, 0.450)
0.293
(0.078, 0.607)

0.86
(0.671, 1.049)
0.356
(0.067, 0.645)
0.125
(âˆ’0.322, 0.572)

0.899
(0.452, 1)
0.251
(0.013, 0.954)
0.291
(0, 0.901)

0.594
(0.545, 0.650)
1.325
(1.239, 1.412)
1.00
âˆ’âˆ’
0.752
(0.647, 0.886)
0.635
(0.482, 0.762)
0.551
(0.409, 0.795)
0.356
(0.159, 0.544)
0.295
(0.095, 0.679)
0.246
(0.087, 0.627)

0.511
(0.414, 0.609)
1.291
(1.051, 1.531)
1.00
âˆ’âˆ’
0.797
(0.578, 1.016)
0.533
(0.338, 0.727)
0.579
(0.326, 0.832)
0.385
(0.124, 0.647)
0.281
(âˆ’0.045, 0.607)
0.431
(0.035, 0.828)

0.525
(0.435, 0.691)
1.294
(1.139, 1.45)
1.00
âˆ’âˆ’
0.783
(0.6, 0.913)
0.533
(0.447, 0.727)
0.557
(0.375, 0.76)
0.394
(0.201, 0.621)
0.277
(0.015, 0.836)
0.393
(0, 1.214)

0.059
(0.024, 0.109)
0.583
(0.483, 0.684)
1.149
(0.986, 1.285)
0.936
(0.773, 1.130)
0.759
(0.573, 0.944)
0.769
(0.554, 1.007)
0.622
(0.409, 0.879)
0.417
(0.120, 0.773)
0.168
(0.001, 0.445)

0.104
(0.061, 0.147)
0.477
(0.366, 0.588)
0.999
(0.796, 1.203)
1.021
(0.771, 1.272)
0.716
(0.454, 0.977)
0.769
(0.463, 1.075)
0.679
(0.344, 1.015)
0.234
(âˆ’0.132, 0.601)
0.189
(âˆ’0.098, 0.476)

0.101
(0.038, 0.186)
0.488
(0.302, 0.755)
1.011
(0.868, 1.213)
1.014
(0.843, 1.228)
0.721
(0.569, 0.945)
0.779
(0.438, 1.104)
0.643
(0.328, 0.967)
0.266
(0.013, 0.896)
0.231
(0, 0.924)

0.627
âˆ’âˆ’
0.253
âˆ’âˆ’
0.224
âˆ’âˆ’
0.137
âˆ’âˆ’
0.565
âˆ’âˆ’
0.717
âˆ’âˆ’
0.347
âˆ’âˆ’
0.619
âˆ’âˆ’
0.94
âˆ’âˆ’
0.41
âˆ’âˆ’
0.501
âˆ’âˆ’

0.59
(0.485, 0.695)
0.252
(0.202, 0.303)
0.234
(0.192, 0.276)
0.143
(0.121, 0.166)
0.81
(0.666, 0.954)
0.75
(0.611, 0.889)
0.361
(0.304, 0.419)
0.656
(0.536, 0.777)
1.088
(0.92, 1.257)
1.135
(0.899, 1.371)
0.752
(0.639, 0.865)

âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’
âˆ’âˆ’

24

Table 6: Comparison of Model Fit to Data on Age-Specific HIV Prevalence from Kapiri
Mposhi, Zambia.

a

Age Groups
15âˆ’9
20âˆ’4
25âˆ’9
30âˆ’9
40âˆ’9
Sum of Squared Errors

WOMEN
Dataa Heuveline
0.082
0.05
0.246
0.111
0.177
0.091
0.198
0.064
0.178
0.042
0.063

Thomas & Clark
0.132
0.28
0.233
0.168
0.113
0.012

Age Groups
15âˆ’9
20âˆ’4
25âˆ’9
30âˆ’9
40âˆ’9
Sum of Squared Errors

MEN
Dataa Heuveline
0.055
0.005
0.058
0.049
0.209
0.097
0.319
0.078
0.123
0.063
0.077

Thomas & Clark
0.014
0.13
0.248
0.201
0.164
0.024

Source: Fylkesnes et al. (1998)

We now turn to the parameters that describe the scale of the HIV epidemic at a given
site. There are several differences between our estimates and those presented by Heuveline
(2003). We estimate that the epidemics are much larger in Fort Portal, Uganda, Kapira
Mposhi, Zambia, and Mutasa, Zimbabwe. Of these, the most troubling is the Zambian site.
Our point estimate is more the double that of Heuvelineâ€™s (1.135 vs. 0.41). This difference is
explored by calculating the predicted values for the data from Kapiri Mposhi, Zambia using
both our estimate of the level parameter and Heuvelineâ€™s; all of the other parameters are
set to Heuvelineâ€™s estimates. The results are presented in Table 6 for both women (upper
panel) and men (lower panel). The observed age-specific prevalence is shown in the column
labeled â€œDataâ€, and Heuvelineâ€™s and our predicted values or shown in the third and fourth
columns, respectively. Each panel also includes the sum of squared errors (SSE) by sex for
each set of estimates. Based on this measure our predicted values fit better than those of
Heuveline for both women (SSE: 0.012 vs. 0.63) and men (SSE: 0.024 vs. 0.077). Similar
results hold for both Fort Portal, Uganda and Mutasa, Zimbabwe.8
The estimates presented above are obtained using data from countries located in East Africa.
This gives rise to the question of regional variation within sub-Saharan Africa. We explore
this question with an application of CCMPP to a population living in a rural area of the
KwaZulu-Natal province of South Africa. Data from this population published by Welz et al.
8

The sum of squared errors for the data from Fort Portal, Uganda are 0.014 (ours) vs. 0.037 (Heuveline)
for women and 0.001 (ours) vs. 0.27 (Heuveline) for men. The corresponding numbers for the data from
Mutasa, Zimbabwe are 0.002 vs. 0.041 for women and 0.010 vs. 0.053 for men.

25

(2007) include age-specific HIV prevalence for the following age groups: 15-19, . . . , 45-49 for
women; and 15-19, . . . , 50-54 for men. The data are further classified by resident status with
non-residents being individuals whose main residence is elsewhere but who maintain regular
contact with the surveyed household through periodic visits. Prevalence is generally much
higher among non-residents which is consistent with the finding that migrants are at a higher
risk of becoming infected. We model this difference by estimating CCMPP with separate
parameters for the level of the epidemic for residents and non-residents. The results from
this model are presented in Table 7 under the column labeled full model. We also report
estimates for a reduced model for which incidence is constrained to be equal across certain
age groups, for women 30-49 and for men 25-34 and 35-54.
Relative to males, incidence among females is much higher in the youngest age group. Incidence peaks among women between the ages of 20 and 29 while the peak for men occurs
during the late twenties and early thirties. There is a relatively large drop in relative incidence after the peak for women. Recall that women between the ages of 25 and 29 serve as
the reference group, with their relative incidence fixed at a value of 1. Relative incidence for
women in the next oldest age group has a 95% confidence interval of (-0.11, 0.51). There is
a similar finding for men, but it is much less pronounced. With respect to the two resident
groups, residents and non-residents, the estimates do not indicate a difference in the level of
the epidemic.
The amount of uncertainty around the estimates in the full model motivated the estimation
of a more parsimonious model. Note how the confidence intervals become increasingly wider
with age9 . With relatively few data we are unable to identify differences between the point
estimates for relative incidence after the peak. The â€˜reduced modelâ€™ column in Table 7
displays estimates for a simpler model that collapses all post-peak age groups for women and
includes only two parameters for relative incidence among men older than 34. The results
show an age pattern similar to that seen for the full model, and there is more precision around
the estimates for this reduced model. We again find little support for the hypothesis that
the HIV epidemic is at a higher level among non-residents, but in both cases the estimates
of epidemic scale are much higher than those from the sites in East Africa.
An interesting comparison between the full and reduced models is to project prevalence and
combine the age groups to obtain an estimate of adult prevalence which can then be compared
to observed prevalence.10 To get a sense of the uncertainty around these estimates we appeal
to asymptotics and sampled CCMPP inputs from a multivariate normal distribution with
the mean and covariance matrix taken from the ML estimates. For each set of inputs in the
sample we run CCMPP and the corresponding outputs are used as a predictive distribution.
The 0.025 and 0.975 quantiles of this predictive distribution are reported together as the
95% predictive interval (95% PI).
Welz et al. (2007) report that 21.5% of all adult residents aged 15-49 are HIV+ (prevalence
for non-residents is not given). Using the ML estimates as the model inputs gives a predicted
9

It should also be pointed out that two of the confidence intervals include negative values that are
problematic since these parameters are naturally bounded at zero.
10
This partially serves as a check for the age distribution of the initial population and the choice of vital
rates.

26

Table 7: CCMPP Parameter Estimates and 95% Confidence Intervals using Data from
KwaZulu-Natal, South Africa.
PARAMETERS
Female Relative Incidence Ratio
15-9
20-4
25-9
30-4
35-39
40-44
45-49
Male Relative Incidence Ratio
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54

FULL MODEL

REDUCED MODEL

0.26
(0.2, 0.33)
0.63
(0.43, 0.82)
1
â€“
0.2
(-0.11, 0.51)
0.4
(0.15, 0.64)
0.25
(0.02, 0.49)
0.21
(0.04, 0.37)

0.27
(0.22, 0.32)
0.64
(0.49, 0.79)
1
â€“
0.29a
(0.24, 0.34)

0.02
(0.01, 0.03)
0.2
(0.14, 0.27)
0.69
(0.47, 0.91)
0.58
(0.28, 0.88)
0.22
(-0.12, 0.56)
0.4
(0.05, 0.74)
0.18
(-0.09, 0.45)
0.32
(0.09, 0.55)

0.02
(0.01, 0.03)
0.21
(0.16, 0.27)
0.65b
(0.54, 0.77)

1.77
(1.41, 2.13)
2.45
(1.86, 3.03)

1.73
(1.5, 1.95)
2.39
(1.95, 2.83)

0.28c
(0.23, 0.34)

Scale
Residents
Non-Residents

a

This is the parameter estimate for women between the ages of 30-49.
This is the parameter estimate for men between the ages of 25-34.
c
This is the parameter estimate for men between the ages of 35-54.
b

27

Figure 2: Projected Prevalence Over Time for Women
Aged 15-49.
(a) Residents
50
40
30
20
10
0

â— â—
â—
â— â—
â—
â—
â— â—

1993

â— â—
â—
â— â—
â—

â— â—
â—
â— â—

Full Model
Reduced Model

â— â—

1988

â— â—
â—
â—
â—
â—

1998

2003

2008

2011

(b) Nonâˆ’Residents
50
40
30
20
10
0

â— â—

â—
â— â—

â— â—

â—
â—
â— â—

â—
â— â—
â—

â— â—
â—
â— â—
â—

â—
â— â—
â—
â— â—
â—

â— â—
â—

Full Model
Reduced Model

â—
â—
â— â—

1988

1993

1998

2003

2008

2011

Note: The horizontal and vertical dashed lines indicate the
prevalence and year, respectively, from the observed data.

28

Figure 3: Projected Prevalence Over Time for Men Aged
15-54.

(a) Residents
50
40
30
20
10
0

Full Model
Reduced Model
â— â—
â— â—

â— â—
â—
â— â—

â— â—
â—
â— â—

1998

2003

â— â—
â—
â— â—

â— â—
â— â—

2008

2011

â— â—

â— â—
â—
â—
â— â—

â— â—

1988

1993

(b) Nonâˆ’Residents
50
40
30
20
10
0

â— â—
â—
â— â—

â— â—

â— â—

â—
â— â—

â—
â— â—

Full Model
Reduced Model

â—
â—
â— â—

1988

1993

â—
â— â—

1998

2003

2008

2011

Note: The horizontal and vertical dashed lines indicate the
prevalence and year, respectively, from the observed data.

prevalence of 25.9% (95% PI: 24.8 â€“ 26.9%) which is much too narrow. Figures 2 & 3 show
the projected prevalence for women and men, respectively. There is a pair of boxplots for
each five-year increment over time up to 2003, the year of data collection, and ten years into
the future. The boxplot on the left (right) refers to the full (reduced) model. Among women
the projections match the observed prevalence of adults much better for non-residents than
for residents. Predicted prevalence is too high for adult female residents. As seen in Panel (a)
of Figure 2 the predictive interval for the full model barely includes the observed prevalence
in 2003, while the corresponding interval for the reduced model is too narrow. Among nonresident women (Panel (b)), for whom prevalence is much higher, the predictive intervals for
both models cover the observed prevalence in 2003. Finally the predictive intervals tend to
be larger for non-residents in both the full and reduced models.
The results for men are shown in Figure 3 with residents presented in Panel (a) and nonresidents in Panel (b). The findings are similar to those of women in that the projections
tend to be too high for residents and too low for non-residents. The fit appears to be slightly
worse among men in that the predictive intervals appear to be too narrow. As found with
women, the reduced model provides very similar projections to the more complicated model.

29

Figure 4: Projected Population Pyramids at 25 Year Intervals for KwaZulu-Natal South Africa.

Stable Age Distribution

80+
75âˆ’9
70âˆ’4
65âˆ’9
60âˆ’4
55âˆ’9
50âˆ’4
45âˆ’9
40âˆ’4
35âˆ’9
30âˆ’4
25âˆ’9
20âˆ’4
15âˆ’9
10âˆ’4
5âˆ’9
0âˆ’4

â—
â— â—

Men

â—
â— â—
â—

â—â—

â—
â—

â—â—

HIVâˆ’
HIV+

â—

â—â—

â—

â—â—

â—

â—â—

â—

â—

â—â—

â— â—

â—

â—

â—â—

â—

â—

â—â—

â—â—

â—

â— â—

â—
â—

â—â—

â—â—

0.05

â—â—

â—â—

â—â—

â—â—

â—

â—â—

0.1

â—â—

â—â—

â—â—

0.15

â—â—

â—â—

â—

â—

â—â—

â—â—

â—â—

â— â—

â—â—

â—â—

â—â—

â—â—

â—â—

â—â—

â—â—

â—â—

â—â—

Women
â—â—

â—â—

â—â—

â—â—

â—â—

â—â—

â—â—

â—
â—

â—â—

â—â—

â—â—

â—â—

â—
â—

â—â—

â—â—

â—â—

0

0.05

0.1

0.15

Proportion

Note: The white bars indicate the proportion of the population
in each age group (HIV- and HIV+ combined), while the black bars
indicate the proportion of the total population who are HIV+ in
each age group. 95% confidence intervals are depicted by the dots.

Given the high level of observed prevalence in KwaZulu-Natal it is interesting to explore
the long term implications of the estimated CCMPP parameters for the population. The
eigenvector corresponding to the largest real eigenvalue of the Leslie matrix is the stable
age distribution (Keyfitz and Caswell, 2005). Population pyramids for the stable equivalent
populations are presented in Figure 4 with men on the left and women on the right. The
white horizontal bars represents the proportion of the total population in an age group and
the black section of each bar indicates the proportion of the population in that age group
that is HIV+. The dots at the end of each bar indicate the 95% confidence intervals around
the proportion represented by the bar â€“ they are very narrow.
In the stable population HIV prevalence resembles the age profile for incidence. There is
an earlier peak for women occurring among women between the ages of 25 and 29. Among
men the peak is at the next older age group, and HIV prevalence is generally lower relative
to women. Prevalence is so high among women (25%) that the female stable population is
actually shrinking. In contrast the male stable population (prevalence 17%) is growing slowly
â€“ which hints at possible pressure on the sex ratio of this population. This â€˜stable equivalentâ€™
30

analysis reveals a potential problem with the current parameterization of the model, revealed
by the proportion older than 65 that is infected. In the absence of widespread antiretroviral
therapy that increases survival with HIV it is unlikely that a large proportion of the elderly
population is infected. Since only those younger than 60 are able to be infected in this model
we expect few to survive to ages much beyond 65. This result may suggest that we are using
survival rates for the HIV+ population that are too high.

5

DISCUSSION

In this article we extend the work of Heuveline (2003) by developing a Leslie matrix representation of his multi-state, HIV-enabled CCMPP and providing new estimates for countries in
East Africa and for a rural population living in the KwaZulu-Natal province of South Africa.
Our findings are broadly similar to Heuvelineâ€™s in that for women incidence peaks between
the ages of 20 and 29 and for men between the ages of 25 and 34, and this is true for both
East Africa and the small population KwaZulu-Natal. Our results also include estimates for
the level of the epidemic at each site from which the data come. The findings reveal substantial variation across East Africa, and the point estimates suggest a much larger epidemic
in KwaZulu-Natal relative to the sites in East Africa.
Focusing on the estimation method we compare the maximum likelihood estimates of the
model parameters to those obtained via a boostrapping procedure. The results raise some
questions concerning the reliability of the maximum likelihood estimates. We find that
several confidence intervals for the CCMPP parameters include negative values which is
troubling since all of the parameters are bounded below by zero. Further the bootstrap
analysis yields much wider confidence intervals, suggesting the ML results understate the
uncertainty around the parameter estimates.11 An alternative approach to estimation is
the use of Bayesian methods. Poole and Raftery (2000) developed the Bayesian melding
technique specifically for use with deterministic models like CCMPP, see also Alkema et al.
(2007).
A Bayesian framework is particularly appealing given the potential need for model comparison, such as the full and reduced models fit to the South African data. Recall that for
the KwaZulu-Natal model the projections for adult prevalence were generally too low for
non-residents and too high for residents. Given that prevalence is higher among women, it
may be inappropriate to model the epidemicâ€™s level for men and women simultaneously since
non-resident men and resident women have similar levels of prevalence. This suggests another model with level parameters for each combination of sex and resident status, perhaps
with addition variation related to the full and reduced specifications shown in Table 7. In
a situation like this it would be invaluable to have an estimation approach that objectively
compares or even combines model fits, and Bayesian approaches exist for both, see Raftery
(1995).
The Leslie matrix is very useful in that it facilitates the actual implementation of the model
11

Recall that the predictive intervals for adult prevalence at the KwaZulu-Natal site were too narrow for
resident men and women as well as non-resident men.

31

and allows us to explore the stable characteristics of a population experiencing an HIV
epidemic. The results suggest that the survival schedules for HIV+ individuals produce unusually large proportions of HIV+ individuals at older ages. This finding may be plausible
with future improvements in the access to health care and the development of new medications to extend life with HIV, but the survival schedules were not originally designed to
capture these potential changes.12 Since it is possible that future health-related innovations
and improvements may take a long time to develop, it would be helpful to have a set of
survival rates informed by data from the populations of interest. Another alternative would
be to include these rates among the list of estimated parameters.
Our current and future work on this model is addressing the limitations and possible improvements discussed above. Most important, we are working on a fully Bayesian implementation
of the estimation procedure and updating the empirical database to include as much contemporary data as possible. The resulting estimates will be more robust and describe the
current state of contemporary HIV epidemics across the African continent.

REFERENCES
Alkema, L., Raftery, A. E., and Clark, S. J. 2007. â€œProbabilistic Projections of HIV Prevalence Using Bayesian Meldingâ€. The Annals of Applied Statistics 1(1):229â€“248.
Bowley, A. 1924. â€œBirths and Population in Great Britainâ€. Economic Journal 34(134):188â€“
92.
Cannan, E. 1895. â€œThe Probability of a Cessation of the Growth of Population in England
and Wales During the Next Centuryâ€. Economic Journal 5(20):505â€“15.
Carpenter, L. M., Nakiyingi, J. S., Ruberantwari, A., Malamba, S. S., Kamali, A., and
Whitworth, J. A. 1997. â€œEstimates of the Impact of HIV Infection on Fertility in a Rural
Ugandan Population Cohortâ€. Health Transition Review 7(Supplement 2):113â€“126.
Chin, J. 1994. â€œA Beginnerâ€™s Guide for Understanding and Using the Epimodel â€“ Version 2:
A Computer Program for Esimation and Projection of AIDS Cases and Deathsâ€. School
of Public Health, University of California, Berkeley.
Chin, J. and Lawnga, S. 1991. â€œEstimation and Projection of Adult AIDS Cases: A Simple
Epidemiological Modelâ€. Bulletin of the World Health Organization 69(4):399â€“406.
Day, J. C. 1996. â€œPopulation Projections of the United States by Age, Sex, Race, and
Hispanic Origin: 1995 to 2050â€. Current Population Reports P25-1130, U.S. Bureau of
the Census, U.S. Government Printing Office, Washington, DC.
Dorn, H. F. 1950. â€œPitfalls in Population Forecasts and Projectionsâ€. Journal of the American Statistical Association 45(251):311â€“334.
12

It would be more satisfying to model this process explicitly by including additional states to CCMPP
for individuals how are on antiretroviral therapies, for example.

32

Fabiani, M., Accorsi, S., Lukwiya, M., Rosolen, T., Ayella, E., Onek, P., and Declich, S.
2001. â€œTrend in HIV-1 Prevalence in an Antenatal Clinic in North Uganda and Adjusted
RAtes for the General Populationâ€. AIDS 15:97â€“103.
Ford, K. and Hosegood, V. 2005. â€œAIDS mortality and the mobility of children in KwaZulu
Natal, South Africaâ€. Demography 42(4):757â€“768.
Fylkesnes, K., Ndhlovu, Z., Dasumba, D., Musonda, R., and Sichone, M. 1998. â€œStudying
the Dynamics of the HIV Epidemic: Population-Based Data Compared with Sentinel
Surveillance in Zambia.â€ AIDS 12:1227â€“34.
Garenne, M. L., Tollman, S. M., Collinson, M. A., and Kahn, K. 2007. â€œFertility trends and
net reproduction in Agincourt, rural South Africa, 1992-2004â€. Scandinavian Journal of
Public Health 35:68â€“76.
Ghys, P. D., Brown, T., Grassly, N. C., Garnett, G., Stanecki, K. A., Stover, J., and Walker,
N. 2004. â€œThe UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemicsâ€. Sexually Transmitted Infections 80:i5â€“i9.
Gray, R. H., Wawer, M. J., Serwadda, D., Sewankambo, N., Li, C., Wabwire-Mangen, F.,
Paxton, L., Kiwanuka, N., Kigozi, G., Konde-Lule, J., Quinn, T. C., and Gaydos, C. A.
1998. â€œPopulation-Based Study of Fertility in Women with HIV-1 Infection in Ugandaâ€.
Lancet 351(9096):98â€“103.
Gregson, S. and Garnett, G. 2000. â€œContrasting Gender Differentials in HIV-1 Prevalence
and Associated Mortality Increase in Eastern and Southern Africa: Artefact of Data or
Natural Course of Epidemics?â€ AIDS 14(Suppl.3):S85â€“99.
Gregson, S., Nyamukapa, C., Lopman, B., Mushati, P., Garnett, G. P., Chandiwana,
S. K., and Anderson, R. M. 2007. â€œCritique of early models of the demographic impact
of HIV/AIDS in sub-Saharan Africa based on contemporary empirical data from Zimbabweâ€. Proceedings of the National Academy of Sciences of the United States of America
104(37):14586â€“14591.
Grosskurth, H., mosha, F., Todd, J., Senkoro, K., Newell, J., Lkokke, A., Changalucha, J.,
West, B., Mayaud, P., Gavyole, A., Gabone, R., Mabey, D., and Hayes, R. 1995. â€œA
Community Trial of the Impact of Improved Sexually Transmitted Disease Treatment on
the HIV Epidemic in Rural Tanzania.â€ AIDS 9:927â€“34.
Heuveline, P. 2003. â€œHIV and Population Dynamics: A General Model and MaximumLikelihood Standards for East Africaâ€. Demography 40(2):217â€“245.
Hira, S., Kamanga, J., Bhat, G., Mwale, C., Tembo, G., Luo, N., and Perine, P. 1989.
â€œPerinatal Transmission of HIV-1 in Zambiaâ€. British Medical Journal 299(6718):1250â€“
52.
Hunter, S. C., Isingo, R., Boerma, J. T., Urassa, M., Mwaluko, G. M. P., and Zaba, B. 2003.
â€œThe association between HIV and fertility in a cohort study in rural Tanzaniaâ€. Journal
of Biosocial Science 35(2):189â€“199.
33

Kahn, K., Tollman, S. M., Collinson, M. A., Clark, S. J., Twine, R., Clark, B. D., Shabangu,
M., Gomez-Olive, F. X., Mokoena, O., and Garenne, M. L. 2007. â€œResearch into health,
population and social transitions in rural South Africa: Data and methods of the agincourt
health and demographic surveillance systemâ€. Scandinavian Journal of Public Health 35:8â€“
20.
Kengeya-Kayondo, J., Kamali, A., Nunn, A., Ruberantwari, A., Wagner, H., and Mulder,
D. 1996. â€œIncidence of HIV-1 nfection in Adults and Socio-Demographic Characteristics
of Seroconverters in a Rural Population in Uganda: 1990-1994â€. International Journal of
Epidemiology 25:1077â€“82.
Keyfitz, N. and Caswell, H. 2005. Applied Mathematical Demograph. Third edition edition.
Springer.
Kilian, A., Gregson, S., Ndyanabangi, B., Walusaga, K., Kipp, W., SahlmÂ¨
uller, G., Garnett,
G., Asiimwe-Okiror, G., Kabagambe, G., Weis, P., and von Sonnenburg, F. 1999. â€œReductions in Risk Behaviour Provide the Most Consistent Explanation of Declining HIV
Prevalence in Uganda.â€ AIDS 13:391â€“98.
Leslie, P. 1945. â€œOn the Use of Matrices in Certain Population Mathematicsâ€. Biometrika
33(3):183â€“212.
Lewis, J. J., Ronsmans, C., Ezeh, A., and Gregson, S. 2004. â€œThe Population Impact of HIV
on Fertility in sub-Saharan Africaâ€. AIDS .
Morgan, D., Mahe, C., Mayanja, B., Okongo, J., Lubega, R., and Whitworth, J. 2002. â€œHIV1 Infection in Rural Africa: Is There a Difference in Median Time to AIDS and Survival
Compared with that in Industrialized Countries?â€ AIDS 16:597â€“603.
Nunn, A., Mulder, D., Kamali, A., Ruberantwari, A., Kengeya-Kayondo, J., and Whitworth,
J. 1997. â€œMortality Associated with HIV-1 Infection Over Five Years in a Rural Ugandan
Population: Cohort Studyâ€. British Medical Journal 315(7111):767â€“71.
Nyirenda, M., Hosegood, V., BÂ¨arnighausen, T., and Newell, M.-L. 2007. â€œMortality Levels
and Trends by HIV Serostatus in Rural South Africaâ€. AIDS 21(suppl 6):S73â€“S79.
Pearl, R. and Reed, L. J. 1920. â€œOn hte Rate of Growth of the Population of the United
States Since 1790 and its Mathematical Representationâ€. Proceedings of the National
Academy of Science 6(6):275â€“288.
Poole, D. and Raftery, A. E. 2000.
The Bayesian Melding Approachâ€.
95(452):1244â€“1255.

â€œInference for Deterministic Simulation Models:
Journal of the American Statistical Association

Pritchett, H. 1891. â€œA Formula for Predicting the Population of the United Statesâ€. Publications of the American Statistical Association 2(14):278â€“286.
R Development Core Team. 2006.
R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. URL
http://www.R-project.org, ISBN 3-900051-07-0.
34

Raftery, A. E. 1995. â€œBayesian Model Selection in Social Researchâ€. Sociological Methodology
25:111â€“163.
Rollins, N., Little, K., Mzolo, S., Horwood, C., and Newell, M.-L. 2007. â€œSurveillance of
mother-to-child transmission prevention programmes at immunization clinics: the case for
universal screeningâ€. AIDS 21:1341â€“1347.
Saidel, T., Sokal, D., Rice, J., Buzingo, T., and Hassig., S. 1996. â€œValidation of a Method
to Estimate Age-Specific Human Immunodeficiency Virus (HIV) Incidence in Developing
Countries Using Population-Based Seroprevalence Dataâ€. American Journal of Epidemiology 144:214â€“23.
Serwadda, D., Wawer, M., Musgrave., S., Sewankambo, N., Kaplan, J., and Gray, R. 1992.
â€œHIV Risk Factors in Three Geographic Strata of Rural Rakai District, Uganda.â€ AIDS
6:983â€“89.
Sewankambo, N., Wawer, M., Gray, R., Serwadda, D., Li, C., Stallings, R., Musgrave, S.,
and Konde-Lule, J. 1994. â€œDemographic Impact of HIV Infection in Rural Rakai District,
Uganda: Results of a Population-Based Cohort Studyâ€. AIDS 8:1707â€“13.
Shao, J., Burbaker, G., Levin, A., Kibauri, A., Massesa, E., Siso, Z., Konings, E., Clayton,
Y., Kumby, D., Alexander, S., Waters, D., Drummond, J., Biggar, R., Scott, G., Miller, G.,
Goedert, J., and Blattner., W. 1994. â€œPopulation-Based Study of HIV-1 Infection in 4,086
Subjectgs in Northwest Tanzaniaâ€. Journal of Acquired Immune Deficiency Syndrome
7:397â€“402.
Slutsker, L., Cabeza, J., Wirima, J., and Steketee, R. 1994. â€œHIV-1 Infection Among Women
of Reproductive Age in a Rural District in Malawiâ€. AIDS 8:1337â€“40.
Sokal, D., Buzingo, T., Nitunga, N., Kadende, P., and Standaert, B. 1993. â€œGeographic
and Temporal Stability of HIV Seroprevalence Among Pregnant Women in Bujumbura,
Burundiâ€. AIDS 7:1481â€“84.
Terceira, N., Gregson, S., Zaba, B., and Mason, P. R. 2003. â€œThe Contribution of HIV to
Fertility Decline in rural Zimbabwe, 1985-2000â€. Population Studies 57(2):149â€“164.
Timaes, I. M. and Jasseh, M. 2004. â€œAdult mortality in sub-Saharan Africa: Evidence from
demographic and health surveysâ€. Demography 41(4):757â€“772.
Todd, J., Balira, R., Grosskurth, H., Mayaud, P., Mosha, F., ka-Gina, G., Klokke, A., Gabbone, R., Gavyole, A., Mabey, D., and Hayes, R. 1997. â€œHIV-Associated Adult Mortality
in a Rural Tanzanian Populationâ€. AIDS 11:801â€“07.
United Nations. 1982. Model Life Tables for Developing Countries. New York: United
Nations.
United Nations. 1998. â€œAIDS, Mortality, and Population Change â€“ Technical Meeting on
the Demographic Impact of HIV/AIDS, Tuesday, 10 November 1998â€. Available online at http://www.un.org/esa/population/pubsarchive/hivmtg/aidsrep.pdf (downloaded
on February 13, 2008).
35

United Nations. 1999. World Population Prospects: the 1998 Revision. New York: United
Nations.
United Nations. 2004. World Population Prospects: the 2002 Revision, volume 3. New York:
United Nations.
Wachter, K. W., Knodel, J. E., and Vanlandingham, M. 2002. â€œAIDS and the elderly of
Thailand: Projecting familial impactsâ€. Demography 39(1):25â€“41.
Wawer, M., Serwadda, D., Musgrave, S., Konde-Lule, J., Musagara, M., and Sewankambo.,
N. 1991. â€œDynamics of Spread of HIV-1 Infection in a Rural District of Ugandaâ€. British
Medical Journal 303(6813):1303â€“06.
Wawer, M., Sewankambo, N., Berkley, S., Serwadda, D., Musgrave, S., Gray, R., Musagara,
M., Stallings, R., and Konde-Lule, J. 1994. â€œIncidence of HIV-1 Infection in a Rural
Region of Ugandaâ€. British Medical Journal 303(6813):1303â€“06.
Welz, T., Hosegood, V., Jaffar, S., Batzing-Feigenbaum, J., Herbst, K., and Newell, M. 2007.
â€œContinued Very High Prevalence on HIV Infection in Rural Kwazulu-Natal, South Africa:
A Population-Based Longitudinal Studyâ€. AIDS 21:1467â€“1472.
Whelpton, P. 1936. â€œAn Empirical Method of Calculating Future Populationâ€. Journal of
the American Statistical Association 31(195):457â€“473.
Working Group on Mother-To-Child Transmission. 1995. â€œRates of mother-to-child transmission of HIV-1 in Arica, America, and Europe: Results from 13 Perinatal Studiesâ€.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 8:506â€“510.
Zaba, B. and Gregson, S. 1998. â€œMeasuring the impact of HIV on fertility in Africaâ€. Aids
12:S41â€“S50.
Zaba, B., Marston, M., Crampin, A. C., Isingo, R., Biraro, S., Barnighausen, T., Lopman,
B., Lutalo, T., Glynn, J. R., and Todd, J. 2007. â€œAge-specific mortality patterns in
HIV-infected individuals: a comparative analysis of African community study dataâ€. Aids
21:S87â€“S96.

36

